Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2544406 | Journal of the American Pharmacists Association | 2006 | 12 Pages |
Abstract
Exenatide offers a wide range of beneficial glucoregulatory effects, including enhancement of glucose-dependent insulin secretion, restoration of first-phase insulin response, suppression of inappropriately elevated glucagon secretion, slowing of gastric emptying, and reduction of food intake. These positive effects depend on the patient/s understanding of the proper administration technique and timing, the need for continued adherence, and what to do if adverse effects occur, all elements that can be conveyed by pharmacists in their counseling and education of patients with type 2 diabetes mellitus.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Triplitt PharmD, BCPS, CDE, Chiquette PharmD, BCPS,